[go: up one dir, main page]
KEGG   DRUG: Raxibacumab
Entry
D05706                      Drug                                   
Name
Raxibacumab (USAN/INN);
Abthrax (TN);
Raxibacumab (TN)
Product
RAXIBACUMAB (Emergent Manufacturing Operations Baltimore LLC)
Formula
C6320H9794N1702O1998S42
Exact mass
142844.5367
Mol weight
142932.40
Remark
ATC code: J06BC02
Product: D05706<US>
Efficacy
Anti-anthrax, Antitoxin
  Disease
Inhalational anthrax [DS:H00328]
  Type
Monoclonal antibody
Target
protective antigen (PA) [KO:K11030]
  Pathway
ko04621  NOD-like receptor signaling pathway
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 J ANTIINFECTIVES FOR SYSTEMIC USE
  J06 IMMUNE SERA AND IMMUNOGLOBULINS
   J06B IMMUNOGLOBULINS
    J06BC Antibacterial monoclonal antibodies
     J06BC02 Raxibacumab
      D05706  Raxibacumab (USAN/INN) <US>
Antimicrobials [BR:br08307]
 Antibacterials
  Other antibacterials
   Monoclonal antibody
    D05706  Raxibacumab (USAN/INN) <US>
New drug approvals in the USA [br08319.html]
 New molecular entities and new therapeutic biological products
  D05706
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D05706
Other DBs
CAS: 565451-13-0
PubChem: 47207367
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system